Content area experts as authors: Helpful or harmful for systematic reviews and meta-analyses?

BMJ (Online)

Volumn 345, Issue 7882, 2012, Pages

  Gøtzsche, Peter C ^a   Ioannidis, John P A ^b  

^a Rigshospitalet   (Denmark)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTENT ANALYSIS; DATA ANALYSIS; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; MEDICAL EXPERT; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL SPECIALIST; META ANALYSIS (TOPIC); PEER REVIEW; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC);

ATTITUDE OF HEALTH PERSONNEL; AUTHORSHIP; CONSENSUS; EXPERT TESTIMONY; HUMANS; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 84868706035     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e7031     Document Type: Review

References (27)

1. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. 2011 www.cochrane-handbook.org.
2. US Institute of Medicine, National Academy of Sciences. Finding what works in health care: standards for systematic reviews. 2011. www.nap.edu/catalog.php?record-id=13059.
3. Agency for Health Research and Policy, Evidence-Practice Centers. Report development. www.ahrq.gov/clinic/epc/.
4. National Institute for Health and Clinical Excellence. How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS. 2009. www.nice.org. uk/media/62F/36/How-NICE-clinical-guidelines-are-developed- 4th-edn-FIANL-LR.pdf.
5. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992;268:240-8.
6. Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012;10:CD009009.
7. Ioannidis JP, Panagiotou OA. Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. JAMA 2011;305:2200-10.
8. Oxman AD, Guyatt GH. The science of reviewing research. Ann NY Acad Sci 1993;703:125-33.
9. Gøtzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 2011;12:249.
10. Siontis GC, Tatsioni A, Katritsis DG, Ioannidis JP. Persistent reservations against contradicted percutaneous coronary intervention indications: citation content analysis. Am Heart J 2009;157:695-701.
11. Tatsioni A, Siontis GC, Ioannidis JP. Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy. J Gen Intern Med 2010;25:914-9.
12. Gøtzsche PC. Mammography screening: truth, lies and controversy. Radcliffe Publishing, 2012.
13. Fugh-Berman AJ. The haunting of medical journals: how ghostwriting sold "HRT." PLoS Med 2010;7:e1000335.
14. Fugh-Berman A, McDonald CP, Bell AM, Bethards EC, Scialli AR. Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles. PLoS Med 2011;8:e1000425.
15. Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000;283:3217-22. (Pubitemid 30422039)
16. Eddy DM, Hasselblad V, Shachter R. Meta-analysis by the confidence profile method: the statistical synthesis of evidence: 3. Academic Press, 1992.
17. Ioannidis JPA, Evans SJW, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141:781-8. (Pubitemid 39524916)
18. Panagiotou OA, Ioannidis JP. Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. J Clin Epidemiol 2012;65:740-7.
19. Gøtzsche PC, Johansen HK. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst Rev 2010;7:CD007851.
20. Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 2001;135:782-95. (Pubitemid 33051262)
21. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012;3:CD007176.
22. Hammarquist C, Burr ML, Gøtzsche PC. House dust mites and control measures in the management of asthma. Cochrane Database Syst Rev 1998;3:CD001187.
23. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005;111:2906-12. (Pubitemid 40823048)
24. Bryson B. A short history of nearly everything. Random House, 2003.
25. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998;338:101-6. (Pubitemid 28042274)
26. Yank V, Rennie D, Bero LA. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ 2007;335:1202-5. (Pubitemid 350273305)
27. Wang AT, McCoy CP, Murad MH, Montori VM. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ 2010;340:c1344.